Sopris Health
Sopris Health
AI medical scribe platform for healthcare providers to reduce documentation burden.
About
What does Sopris Health do?
Sopris Health develops an AI-powered medical scribe application designed to minimize the administrative burden on healthcare providers by automating documentation and data entry. The platform utilizes voice-driven technology to capture and understand patient-provider conversations, enabling physicians to focus more on patient care and less on manual data input.
Where is Sopris Health headquartered?
Sopris Health is headquartered in San Francisco, United States.
When was Sopris Health founded?
Sopris Health was founded in 2018.
What industry does Sopris Health operate in?
Sopris Health operates in HealthTech, AI-Driven Healthcare, Medical Records Systems, Conversational AI, Voice AI, SaaS.
What is Sopris Health's current status?
Sopris Health's current operating status is: Inactive.
AI-powered platform for healthcare providers to manage patient WhatsApp messages efficiently.
AI-powered platform for personalized weight management and health coaching.
Clinical Trial Discovery by ENSCORE.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
SYLARIS™ offers premium wearable wellness patches and clinical-grade skincare designed for effortless, intentional, and beautifully designed self-care rituals.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Purpose-built WordPress plugins for healthcare and the agencies that serve them.
An entrant is a company tagged HealthTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 6 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.